Department of Physical Therapy and Human Movement Sciences, Northwestern University, Chicago, IL, USA.
Department of Kinesiology and Nutrition, University of Illinois at Chicago, Chicago, IL, USA.
Neuromodulation. 2022 Aug;25(6):866-876. doi: 10.1111/ner.13476. Epub 2022 Jun 14.
Bilateral subthalamic nucleus deep brain stimulation (STN DBS) in Parkinson's disease (PD) can have detrimental effects on eye movement inhibitory control. To investigate this detrimental effect of bilateral STN DBS, we examined the effects of manipulating STN DBS amplitude on inhibitory control during the antisaccade task. The prosaccade error rate during the antisaccade task, that is, directional errors, was indicative of impaired inhibitory control. We hypothesized that as stimulation amplitude increased, the prosaccade error rate would increase.
Ten participants with bilateral STN DBS completed the antisaccade task on six different stimulation amplitudes (including zero amplitude) after a 12-hour overnight withdrawal from antiparkinsonian medication.
We found that the prosaccade error rate increased as stimulation amplitude increased (p < 0.01). Additionally, prosaccade error rate increased as the modeled volume of tissue activated (VTA) and STN overlap decreased, but this relationship depended on stimulation amplitude (p = 0.04).
Our findings suggest that higher stimulation amplitude settings can be modulatory for inhibitory control. Some individual variability in the effect of stimulation amplitude can be explained by active contact location and VTA-STN overlap. Higher stimulation amplitudes are more deleterious if the active contacts fall outside of the STN resulting in a smaller VTA-STN overlap. This is clinically significant as it can inform clinical optimization of STN DBS parameters. Further studies are needed to determine stimulation amplitude effects on other aspects of cognition and whether inhibitory control deficits on the antisaccade task result in a meaningful impact on the quality of life.
帕金森病(PD)患者双侧丘脑底核(STN)深部脑刺激(DBS)可能对眼球运动抑制控制产生不利影响。为了研究双侧 STN DBS 的这种不利影响,我们考察了调节 STN DBS 幅度对反扫视任务中抑制控制的影响。反扫视任务中的顺向扫视错误率,即方向错误,提示抑制控制受损。我们假设随着刺激幅度的增加,顺向扫视错误率会增加。
10 名接受双侧 STN DBS 的参与者在停用抗帕金森药物 12 小时后,在 6 种不同的刺激幅度(包括零幅度)下完成反扫视任务。
我们发现顺向扫视错误率随刺激幅度的增加而增加(p<0.01)。此外,随着被激活的组织体积(VTA)和 STN 重叠减少,顺向扫视错误率增加,但这种关系取决于刺激幅度(p=0.04)。
我们的发现表明,较高的刺激幅度设置可能对抑制控制具有调节作用。刺激幅度效应的一些个体差异可以通过活性接触位置和 VTA-STN 重叠来解释。如果活性触点落在 STN 之外,导致 VTA-STN 重叠较小,那么较高的刺激幅度会更具危害性。这在临床上具有重要意义,因为它可以为 STN DBS 参数的临床优化提供信息。需要进一步的研究来确定刺激幅度对认知其他方面的影响,以及反扫视任务中的抑制控制缺陷是否对生活质量产生有意义的影响。